A series of studies with mice lacking both FABP4 and FABP5 (double knockout (DKO) mice) provided evidence that FABP4/5 are involved in the development of metabolic diseases, including diet-induced obesity, type 2 diabetes and insulin resistance [6–8]. Here, FABP4 is linked to obesity disorder.